JP2018012722A5 - - Google Patents

Download PDF

Info

Publication number
JP2018012722A5
JP2018012722A5 JP2017171209A JP2017171209A JP2018012722A5 JP 2018012722 A5 JP2018012722 A5 JP 2018012722A5 JP 2017171209 A JP2017171209 A JP 2017171209A JP 2017171209 A JP2017171209 A JP 2017171209A JP 2018012722 A5 JP2018012722 A5 JP 2018012722A5
Authority
JP
Japan
Prior art keywords
kit
composition
leucine
combination
subject
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2017171209A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018012722A (ja
Filing date
Publication date
Priority claimed from US13/662,345 external-priority patent/US9198454B2/en
Application filed filed Critical
Publication of JP2018012722A publication Critical patent/JP2018012722A/ja
Publication of JP2018012722A5 publication Critical patent/JP2018012722A5/ja
Pending legal-status Critical Current

Links

JP2017171209A 2012-03-08 2017-09-06 エネルギー代謝を調節するための組成物、方法およびキット Pending JP2018012722A (ja)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US201261608595P 2012-03-08 2012-03-08
US61/608,595 2012-03-08
US201261656407P 2012-06-06 2012-06-06
US61/656,407 2012-06-06
US13/662,345 US9198454B2 (en) 2012-03-08 2012-10-26 Compositions, methods, and kits for regulating energy metabolism
US13/662,345 2012-10-26

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2014561175A Division JP6210517B2 (ja) 2012-03-08 2013-03-08 エネルギー代謝を調節するための組成物、方法およびキット

Publications (2)

Publication Number Publication Date
JP2018012722A JP2018012722A (ja) 2018-01-25
JP2018012722A5 true JP2018012722A5 (enExample) 2018-05-24

Family

ID=49114651

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2014561175A Expired - Fee Related JP6210517B2 (ja) 2012-03-08 2013-03-08 エネルギー代謝を調節するための組成物、方法およびキット
JP2017171209A Pending JP2018012722A (ja) 2012-03-08 2017-09-06 エネルギー代謝を調節するための組成物、方法およびキット

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2014561175A Expired - Fee Related JP6210517B2 (ja) 2012-03-08 2013-03-08 エネルギー代謝を調節するための組成物、方法およびキット

Country Status (7)

Country Link
US (4) US9198454B2 (enExample)
EP (1) EP2822579B1 (enExample)
JP (2) JP6210517B2 (enExample)
AU (2) AU2013229779B2 (enExample)
CA (1) CA2866718C (enExample)
HK (1) HK1205942A1 (enExample)
WO (1) WO2013134736A1 (enExample)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108114285A (zh) 2011-07-15 2018-06-05 纽斯尔特科学公司 用于调节代谢途径的组合物和方法
US9198454B2 (en) 2012-03-08 2015-12-01 Nusirt Sciences, Inc. Compositions, methods, and kits for regulating energy metabolism
CN104918610B (zh) 2012-11-13 2018-04-10 纽斯尔特科学公司 用于增强能量代谢的组合物和方法
BR112015023310A2 (pt) 2013-03-15 2017-07-18 Nusirt Sciences Inc composições, métodos e kits para redução de níveis lipídicos
RU2016138136A (ru) 2014-02-27 2018-04-02 Нусерт Сайенсиз, Инк. Композиции и способы уменьшения или профилактики жировой дистрофии печени
WO2016049236A1 (en) * 2014-09-24 2016-03-31 Nusirt Sciences, Inc. Compositions, methods and kits for treatment of diabetes and/or hyperlipidemia
WO2017040407A1 (en) * 2015-09-01 2017-03-09 Nusirt Sciences, Inc. Compositions and methods for the reduction or prevention of non-alcoholic steatohepatitis (nash)
WO2017073729A1 (ja) * 2015-10-30 2017-05-04 恭正 加藤 糖尿病治療用組成物
US11701336B2 (en) 2015-10-30 2023-07-18 Yasumasa Kato Method of determining composition effective for treating diabetes
JOP20190146A1 (ar) 2016-12-19 2019-06-18 Axcella Health Inc تركيبات حمض أميني وطرق لمعالجة أمراض الكبد
IT201700087359A1 (it) 2017-07-28 2019-01-28 Professional Dietetics Spa Composizioni comprendenti amino acidi per l'uso nel trattamento di malattie associate a disfunzione mitocondriale
IT201700087376A1 (it) 2017-07-28 2019-01-28 Professional Dietetics Spa Composizioni comprendenti amino acidi per l'uso nel trattamento di malattie associate a disfunzione mitocondriale
US10682325B2 (en) 2017-08-14 2020-06-16 Axcella Health Inc. Compositions and methods for the treatment of liver diseases and disorders associated with one or both of hyperammonemia or muscle wasting
JP2021527670A (ja) 2018-06-20 2021-10-14 アクセラ・ヘルス・インコーポレイテッドＡｘｃｅｌｌａ Ｈｅａｌｔｈ Ｉｎｃ． 筋肉中の脂肪浸潤の治療のための組成物及び方法
IT201800006725A1 (it) 2018-06-27 2019-12-27 Composizioni comprendenti aminoacidi per l'uso nella prevenzione e nel trattamento di malattie epatiche
US10568352B1 (en) 2018-10-25 2020-02-25 Wiser Concepts, LLC Nutritional compositions and methods of treatment therewith
IT202000000442A1 (it) 2020-01-13 2021-07-13 Professional Dietetics Spa Composizioni comprendenti amino acidi per l'uso nella prevenzione e nel trattamento di effetti collaterali della chemioterapia
JP7795755B2 (ja) * 2020-04-17 2026-01-08 共栄化学工業株式会社 皮膚外用剤
CN112056272A (zh) * 2020-09-16 2020-12-11 华中农业大学 一种评价甜味剂摄入对小鼠影响的方法
US12029718B2 (en) 2021-11-09 2024-07-09 Cct Sciences, Llc Process for production of essentially pure delta-9-tetrahydrocannabinol
WO2024186730A1 (en) * 2023-03-03 2024-09-12 Grads Innovation Compositions for enhanced metabolic oxidation of fatty acids

Family Cites Families (143)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3810994A (en) 1972-06-01 1974-05-14 Ethyl Corp Method and composition for treating obesity
DK150008C (da) 1981-11-20 1987-05-25 Benzon As Alfred Fremgangsmaade til fremstilling af et farmaceutisk oralt polydepotpraeparat
US4769027A (en) 1984-08-15 1988-09-06 Burroughs Wellcome Co. Delivery system
US4897268A (en) 1987-08-03 1990-01-30 Southern Research Institute Drug delivery system and method of making the same
US5087624A (en) 1989-03-21 1992-02-11 Nutrition 21 Chromic picolinate treatment
US5886012A (en) 1989-03-22 1999-03-23 Peter K. T. Pang Method of treatment for disease associated with excessive PHF using combination therapy involving exogenous calcium and calcium channel blockers
US4992470A (en) 1990-02-08 1991-02-12 Iowa State University Research Foundation, Inc. Method of enhancing immune response of mammals
US5250534A (en) 1990-06-20 1993-10-05 Pfizer Inc. Pyrazolopyrimidinone antianginal agents
US6764697B1 (en) 1991-06-27 2004-07-20 Alza Corporation System for delaying drug delivery up to seven hours
US5419283A (en) 1992-04-08 1995-05-30 Ciuffo Gatto S.R.L. Animal chew toy of starch material and degradable ethylene copolymer
JP3219838B2 (ja) 1992-05-12 2001-10-15 沖電気工業株式会社 半導体素子の製造方法
GB9301192D0 (en) 1993-06-09 1993-06-09 Trott Francis W Flower shaped mechanised table
LU88369A1 (fr) 1993-07-12 1994-04-01 Michel Urso Prof Medecin Et Ch Acides aminés à chaînes ramifiées
US5339771A (en) 1993-09-15 1994-08-23 Axelrod Herbert R Animal chew toy containing animal meal
US5395626A (en) 1994-03-23 1995-03-07 Ortho Pharmaceutical Corporation Multilayered controlled release pharmaceutical dosage form
US5616569A (en) 1994-03-28 1997-04-01 The Iams Company Pet food product containing fermentable fibers and process for treating gastrointestinal disorders
US6048903A (en) 1994-05-03 2000-04-11 Robert Toppo Treatment for blood cholesterol with trans-resveratrol
EP0873754B1 (en) 1996-01-09 2003-07-30 Riken Amino acid compositions
US6395292B2 (en) 1996-02-02 2002-05-28 Alza Corporation Sustained delivery of an active agent using an implantable system
US6919373B1 (en) 1996-11-12 2005-07-19 Alza Corporation Methods and devices for providing prolonged drug therapy
US6004996A (en) 1997-02-05 1999-12-21 Hoffman-La Roche Inc. Tetrahydrolipstatin containing compositions
IT1291113B1 (it) 1997-03-20 1998-12-29 Sigma Tau Ind Farmaceuti Composizione nutritiva terapeutica per soggetti affetti da diabete mellito
MY125849A (en) 1997-07-25 2006-08-30 Alza Corp Osmotic delivery system, osmotic delivery system semipermeable body assembly, and method for controlling delivery rate of beneficial agents from osmotic delivery systems
GB9723059D0 (en) 1997-10-31 1998-01-07 Mars Uk Ltd Pet food
AU3826099A (en) 1998-05-04 1999-11-23 Andreas Johannes Kesel Monomeric, oligomeric and polymeric knoevenagel condensation products
US6031000A (en) 1998-06-23 2000-02-29 Iowa State University Research Foundation, Inc. Composition comprising β-hydroxy-β-methylbutyric acid and at least one amino acid and methods of use
ATE260642T1 (de) 1998-12-17 2004-03-15 Alza Corp Umwandlung von flüssigkeitsgefüllten gelatinkapseln in systeme mit gesteuerter wirkstoffabgabe durch mehrfache beschichtungen
US6797283B1 (en) 1998-12-23 2004-09-28 Alza Corporation Gastric retention dosage form having multiple layers
BR0008857A (pt) 1999-03-08 2001-12-18 Medicure Inc Análogos de piridoxal para distúrbios da vitaminab-6
FR2790645B1 (fr) 1999-03-12 2001-06-08 Arkopharma Laboratoires Complement alimentaire et procede de traitement cosmetique a base d' un extrait de raisin riche en polyphenols
WO2001021165A1 (en) 1999-09-21 2001-03-29 Rutgers, The State University Resveratrol analogs for prevention of disease
US6527711B1 (en) 1999-10-18 2003-03-04 Bodymedia, Inc. Wearable human physiological data sensors and reporting system therefor
US6280779B1 (en) 1999-12-28 2001-08-28 Colgate-Palmolive Company Pet food for maintaining normal bowel health
US7261690B2 (en) 2000-06-16 2007-08-28 Bodymedia, Inc. Apparatus for monitoring health, wellness and fitness
US7689437B1 (en) 2000-06-16 2010-03-30 Bodymedia, Inc. System for monitoring health, wellness and fitness
US6605038B1 (en) 2000-06-16 2003-08-12 Bodymedia, Inc. System for monitoring health, wellness and fitness
US8398546B2 (en) 2000-06-16 2013-03-19 Bodymedia, Inc. System for monitoring and managing body weight and other physiological conditions including iterative and personalized planning, intervention and reporting capability
US6384087B1 (en) 2000-09-01 2002-05-07 University Of Tennesseee Research Corporation, Inc. Materials and methods for the treatment or prevention of obesity
DK1345500T3 (da) 2000-12-29 2008-11-24 Martin Francis Gannon Foderprodukt til dyr
IL157367A0 (en) 2001-03-09 2004-02-19 Nestle Sa Composition improving age-related physiological deficits and increasing longevity
US6338862B1 (en) 2001-03-26 2002-01-15 Sarfaraz K Niazi Composition and method of use in treating sexual dysfunction using cGMP-specific phosphodiesterase type 5 inhibitors
US6595929B2 (en) 2001-03-30 2003-07-22 Bodymedia, Inc. System for monitoring health, wellness and fitness having a method and apparatus for improved measurement of heat flow
WO2003042362A2 (en) 2001-11-09 2003-05-22 Dana-Farber Cancer Institute, Inc. PGC-1β, A NOVEL PGC-1 HOMOLOGUE AND USES THEREFOR
US20030187055A1 (en) 2002-02-25 2003-10-02 Riker Donald K. Synergistic pharmaceutical combinations for treating obesity
CN1320886C (zh) 2002-05-17 2007-06-13 杜克大学 安非他酮与抗惊厥药在制备治疗肥胖症的药物的用途
MXPA05000224A (es) 2002-06-26 2005-06-03 Alza Corp Piston de volumen eficiente, minimamente deformable, para sistemas de suministro osmotico de farmacos.
FR2841784B1 (fr) 2002-07-08 2007-03-02 Composition a base de derives de 1,3-diphenylprop-2en-1-one substitues, preparation et utilisations
US7020508B2 (en) 2002-08-22 2006-03-28 Bodymedia, Inc. Apparatus for detecting human physiological and contextual information
MXPA05003688A (es) 2002-10-09 2005-09-30 Bodymedia Inc Metodo y aparato para autocontabilizar los estados continuos o discretos del cuerpo utilizando parametros fisiologicos y/o del entorno.
US20050064070A1 (en) 2002-10-11 2005-03-24 Jeffrey Liebrecht Beverage compositions for use in rehydration and nutrition during athletic exercise and methods of making same
US7744930B2 (en) 2002-11-22 2010-06-29 Shaklee Corporation Compositions, methods and kits for enhancing weight loss while inhibiting loss of lean body mass
US20040254357A1 (en) 2002-12-19 2004-12-16 Zaloga Gary P. Fatty acid phenolic conjugates
US7288570B2 (en) * 2002-12-20 2007-10-30 Nutricia N.V. Stimulation of in vivo production of proteins
US20040120983A1 (en) 2002-12-23 2004-06-24 Philip Connolly Nutritional supplement
EP1605779A1 (en) 2003-03-13 2005-12-21 Red Arrow Products Co., LLC Browning composition for application to a film for holding a food product
US20040186046A1 (en) 2003-03-17 2004-09-23 Pfizer Inc Treatment of type 1 diabetes with PDE5 inhibitors
JP2006520335A (ja) 2003-03-18 2006-09-07 ノバルティス アクチエンゲゼルシャフト 脂肪酸とアミノ酸を含有する組成物
US7160565B2 (en) 2003-03-31 2007-01-09 Breakthru Products, Llc Hydration beverage and method of delivering nutrients
DK1638586T3 (da) 2003-05-14 2008-06-23 Indus Biotech Pvt Ltd Synergistisk sammensætning til behandling af diabetes mellitus
WO2005003766A2 (en) 2003-06-13 2005-01-13 Whitehead Institute For Biomedical Research Methods of regulating metabolism and mitochondrial function
EP1643863A2 (en) 2003-07-10 2006-04-12 Carl A. Forest Foods, beverages, condiments, spices and salad dressings with specialized supplements
JP2005097273A (ja) * 2003-08-19 2005-04-14 Toyo Shinyaku:Kk 運動能力向上組成物
KR101084554B1 (ko) 2003-09-12 2011-11-17 보디미디어 인코퍼레이티드 심장 관련 파라미터를 측정하기 위한 방법 및 장치
US7495101B2 (en) 2003-11-19 2009-02-24 Dsm Ip Assets B.V. Manufacture of vitamin B6
WO2005049006A1 (ja) 2003-11-21 2005-06-02 Ajinomoto Co., Inc. 糖尿病治療剤
BRPI0416881A (pt) 2003-11-26 2007-02-06 Hills Pet Nutrition Inc método para reduzir odor excrementos de um animal doméstico.
CN1921842A (zh) * 2003-12-24 2007-02-28 努特里奇亚有限公司 包含泛酸或其衍生物的组合物及其刺激食欲的应用
CA2548671C (en) 2003-12-29 2015-02-24 President And Fellows Of Harvard College Compositions for treating or preventing obesity and insulin resistance disorders
US8017634B2 (en) 2003-12-29 2011-09-13 President And Fellows Of Harvard College Compositions for treating obesity and insulin resistance disorders
US20050215882A1 (en) 2004-03-23 2005-09-29 The Regents Of The University Of Michigan Noninvasive method to determine fat content of tissues using MRI
EP1781261A1 (en) 2004-06-17 2007-05-09 Forest Laboratories, Inc. Modified release formulation of memantine
US20070244202A1 (en) 2004-06-28 2007-10-18 Kao Corporation Ampk Activator
JP5070052B2 (ja) 2004-08-17 2012-11-07 ザ・ジョンズ・ホプキンス・ユニバーシティ Ｐｄｅ５阻害剤組成物及び心臓疾患を治療する方法
US8252321B2 (en) 2004-09-13 2012-08-28 Chrono Therapeutics, Inc. Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, alzheimer's disease, sleep disorders, parkinson's disease, aids, epilepsy, attention deficit disorder, nicotine addiction, cancer, headache and pain control, asthma, angina, hypertension, depression, cold, flu and the like
CA2588818A1 (en) 2004-11-29 2006-06-01 Toyo Shinyaku Co., Ltd. Athletic ability enhancing composition
US20060115555A1 (en) 2004-12-01 2006-06-01 Foulger Sidney W Nutritional supplements containing xanthone extracts
AU2006218404A1 (en) 2005-03-03 2006-09-08 Sirtris Pharmaceuticals, Inc. N-phenyl benzamide derivatives as sirtuin modulators
US20070014833A1 (en) 2005-03-30 2007-01-18 Sirtris Pharmaceuticals, Inc. Treatment of eye disorders with sirtuin modulators
EA013474B1 (ru) 2005-06-16 2010-04-30 Форест Лэборэтериз, Инк. Композиция в виде гранул с модифицированным и немедленным высвобождением мемантина
JP5203193B2 (ja) 2005-08-04 2013-06-05 サートリス ファーマシューティカルズ， インコーポレイテッド サーチュイン調節化合物としてのイミダゾ［２，１−ｂ］チアゾール誘導体
US7855289B2 (en) 2005-08-04 2010-12-21 Sirtris Pharmaceuticals, Inc. Sirtuin modulating compounds
US8088928B2 (en) 2005-08-04 2012-01-03 Sirtris Pharmaceuticals, Inc. Sirtuin modulating compounds
US8093401B2 (en) 2005-08-04 2012-01-10 Sirtris Pharmaceuticals, Inc. Sirtuin modulating compounds
US20070077310A1 (en) 2005-10-03 2007-04-05 University Of Tennessee Research Foundation Methods of reducing the production of reactive oxygen species and methods of screening or identifying compounds and compositions that reduce the production of reactive oxygen species
JP2007161675A (ja) * 2005-12-16 2007-06-28 Taisho Pharmaceut Co Ltd 疲労改善内服剤
WO2007082231A1 (en) 2006-01-10 2007-07-19 Hill's Pet Nutrition, Inc. Compositions and method for promoting fat loss
US20110191871A1 (en) 2006-02-28 2011-08-04 Trustees Of Boston University Methods to identify factors associated with muscle growth and uses thereof
US7691388B2 (en) 2006-03-24 2010-04-06 Ocean Nutrition Canada Limited Compositions comprising Porphyra and methods of making and using thereof
EP2007221A4 (en) 2006-04-05 2010-07-28 Chemaphor Inc CAROTINO-ADDED FOOD SUPPLEMENT
JP2007306851A (ja) * 2006-05-18 2007-11-29 仁 ▲吉▼井 食塩組成物およびその製造方法
US20070286909A1 (en) * 2006-06-07 2007-12-13 Daniel S. Smith Amino acid compositions
US20090291958A1 (en) 2006-06-08 2009-11-26 Auspex Pharmaceuticals, Inc. Substituted PDE5 inhibitors
CA2658394C (en) 2006-07-12 2016-08-16 University Of Tennessee Research Foundation Substituted acylanilides and methods of use thereof
JP2008063328A (ja) 2006-08-07 2008-03-21 Kowa Co 糸球体疾患治療剤
JP5507802B2 (ja) 2006-08-10 2014-05-28 花王株式会社 筋肉老化抑制剤
AU2007341981A1 (en) 2006-12-29 2008-07-10 The Salk Institute For Biological Studies Methods for enhancing exercise performance
RU2486902C2 (ru) 2007-01-16 2013-07-10 АЙПИИНТЛ, ЭлЭлСи Новая композиция для лечения метаболического синдрома
US20090006458A1 (en) 2007-02-16 2009-01-01 Stivoric John M Life bytes
CN101657106B (zh) 2007-02-23 2013-02-06 希尔氏宠物营养品公司 用于控制动物体重的组合物和方法
WO2008115563A1 (en) * 2007-03-19 2008-09-25 University Of Florida Research Foundation, Inc. Liquid nutrient composition for improving performance
US20080233244A1 (en) 2007-03-23 2008-09-25 Solae, Llc Animal food compositions and treats
WO2008119070A1 (en) 2007-03-28 2008-10-02 Trustees Of Boston University Methods of treatment using sirt modulators and compositions containing sirt1 modulators
US20080268038A1 (en) * 2007-04-26 2008-10-30 Wolfe Robert R Compositions and Approaches for Increasing Diet Induced Thermogenesis, Inducing Weight Loss and Maintaining Muscle Mass and Strength
EP2163252A4 (en) 2007-05-17 2012-01-11 Kaneka Corp COMPOSITION WITH POLYPHENOL FROM CANDY
WO2008153945A2 (en) 2007-06-06 2008-12-18 University Of South Florida Nutraceutical co-crystal compositions
WO2008157537A2 (en) 2007-06-19 2008-12-24 Ironwood Pharmaceuticals, Inc Compositions and methods of use for treating or preventing lipid related disorders
TW200918542A (en) 2007-06-20 2009-05-01 Sirtris Pharmaceuticals Inc Sirtuin modulating compounds
TW200916472A (en) 2007-06-20 2009-04-16 Sirtris Pharmaceuticals Inc Sirtuin modulating compounds
WO2009002867A2 (en) 2007-06-26 2008-12-31 Nutrition 21, Inc. Multiple unit dosage form having a therapeutic agents in combination with a nutritional supplement
US7989007B2 (en) 2007-07-03 2011-08-02 Vincent James Enterprises, Llc Weight loss composition
US20090139764A1 (en) 2007-09-07 2009-06-04 Nike,Inc. Wearable device assembly having athletic functionality
US20110082189A1 (en) 2007-10-23 2011-04-07 President And Fellows Of Harvard College Use of compounds activating sirt-3 for mimicking exercise
US20090156648A1 (en) 2007-12-12 2009-06-18 Iovate T. & P. Inc. Preparations containing pyridoxine and alpha-hydroxyisocaproic acid (HICA)
BRPI0905952A2 (pt) 2008-02-04 2015-06-30 Mercury Therapeutics Composto e sais do mesmo e compição farmacêutica
WO2009111472A2 (en) 2008-03-03 2009-09-11 Nike, Inc. Interactive athletic equipment system
WO2009124193A1 (en) 2008-04-02 2009-10-08 Nike, Inc. Wearable device assembly having athletic functionality
GB0809665D0 (en) 2008-05-28 2008-07-02 Mars Uk Ltd Food product
WO2010004982A1 (ja) 2008-07-07 2010-01-14 持田製薬株式会社 脂質異常症の改善または治療薬
CA2733907C (en) 2008-08-15 2019-03-12 Nestec S.A. Use of soy isoflavones for enhancing metabolism in canines
MX2011002982A (es) 2008-09-19 2011-04-11 Nestec Sa Soporte nutricional del sistema inmunologico durante el tratamiento anti-cancer.
US20100173024A1 (en) 2008-12-01 2010-07-08 LifeSpan Extension, LLC Methods and compositions for altering health, wellbeing, and lifespan
US9122250B2 (en) 2009-04-26 2015-09-01 Nike, Inc. GPS features and functionality in an athletic watch system
BRPI0904259A2 (pt) 2009-05-06 2012-02-28 Provets-simões Laboratório Ltda suplemento alimentar para pássaros em fase reprodutiva
CN102573496B (zh) 2009-07-01 2015-08-26 玛格塞蒂克斯公司 缓释镁组合物及其用途
US8691303B2 (en) 2009-07-31 2014-04-08 The Iams Company Dusted animal food
US20110064720A1 (en) 2009-09-16 2011-03-17 Daniel Moses Amato Dietary Supplement Compositions and Methods of Making and Using the Same
CN102630161A (zh) 2009-09-18 2012-08-08 珀利弗诺斯自然有限公司 通过用岩藻黄质和石榴油酸的组合激活去乙酰化酶Sirtuin来延缓衰老过程的方法
WO2011051974A1 (en) 2009-10-29 2011-05-05 Nutracryst Therapeutics Private Limited Metformin and a-amino acids
US8173181B2 (en) 2009-11-09 2012-05-08 Bio-Engineered Supplements & Nutrition, Inc. Method and composition for improved anabolism
WO2011087708A1 (en) 2010-01-13 2011-07-21 Dodds W Jean Animal food compositions for promoting liver cleansing and mitigations of intestinal dysbiosis
US20120309716A1 (en) 2010-02-03 2012-12-06 Kao Corporation Motor Function Improver
US20110208153A1 (en) 2010-02-24 2011-08-25 John Alvey Formulations and methods for nutrient delivery
US20120058088A1 (en) 2010-06-28 2012-03-08 Resveratrol Partners, Llc Resveratrol-Containing Compositions And Methods Of Use
CN102077936B (zh) * 2010-09-20 2013-04-24 王强 一种糖尿病患者专用的海洋特膳食品
US9167991B2 (en) 2010-09-30 2015-10-27 Fitbit, Inc. Portable monitoring devices and methods of operating same
WO2012060884A1 (en) 2010-11-04 2012-05-10 Nestec S.A. Methods and compositions for preventing and treating osteoarthritis
SG191855A1 (en) 2011-01-07 2013-08-30 Elcelyx Therapeutics Inc Chemosensory receptor ligand-based therapies
WO2012097064A1 (en) 2011-01-13 2012-07-19 Abbott Laboratories Nutritional compositions and methods for controlling blood glucose
US20120231087A1 (en) 2011-03-07 2012-09-13 Olympic Seafood Compositions And Methods for Nutritional Supplementation
CN108114285A (zh) 2011-07-15 2018-06-05 纽斯尔特科学公司 用于调节代谢途径的组合物和方法
US9198454B2 (en) 2012-03-08 2015-12-01 Nusirt Sciences, Inc. Compositions, methods, and kits for regulating energy metabolism
EP2986140A4 (en) 2013-03-15 2016-10-19 Nusirt Sciences Inc COMPOSITIONS, PROCESSES AND KIT FOR TREATMENT OF PETS
RU2016138136A (ru) 2014-02-27 2018-04-02 Нусерт Сайенсиз, Инк. Композиции и способы уменьшения или профилактики жировой дистрофии печени

Similar Documents

Publication Publication Date Title
JP2018012722A5 (enExample)
JP2015510888A5 (enExample)
JP2009534323A5 (enExample)
RU2009111391A (ru) ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ, СОДЕРЖАЩИЕ чГР, ДЛЯ ПЕРОРАЛЬНОГО ВВЕДЕНИЯ
IL286592B2 (en) Amino acid compositions for the treatment of liver disease
JP2016505804A5 (enExample)
JP2020502183A5 (enExample)
RU2015147876A (ru) Пероральная дозированная форма соединений глюкагоноподобного пептида-1
JP2006510711A5 (enExample)
RU2600440C3 (ru) Твердые композиции, содержащие агонист glp-1 и соль n-(8-(2-гидроксибензоил)амино)каприловой кислоты
CN101049500A (zh) 一种氨基酸组合物
JP2017507973A5 (enExample)
RU2016135952A (ru) Композиции ингибитора дофа-декарбоксилазы
RU2013150659A (ru) Пероральное введение кальцитонина
CN100464647C (zh) 用于食品或饮料及医用的能使体温升高的含氨基酸的试剂
JP2004123564A (ja) 中枢機能改善用アミノ酸組成物
UA102111C2 (uk) Фармацевтична композиція у вигляді разової пероральної дози, що містить леводопу, карбідопу і ентакапон або їх солі
JP2004534073A5 (enExample)
JPH03204814A (ja) 腎不全用経口アミノ酸製剤
MX2022012693A (es) Composicion que comprende metilfolato.
JP2018502893A5 (enExample)
RU2010130889A (ru) Композиция для лечения неинфекционного воспаления
JPWO2019246310A5 (enExample)
JP2009515953A5 (enExample)
JP2017007966A5 (enExample)